Neuromodulation: Technology at the Neural Interface is the preeminent journal in the area of neuromodulation, providing our readership with the state of the art clinical, translational, and basic science research in the field. For clinicians, engineers, scientists and members of the biotechnology industry alike, Neuromodulation provides timely and rigorously peer-reviewed articles on the technology, science, and clinical application of devices that interface with the nervous system to treat disease and improve function.

Representing the needs of the broad neuromodulation community, the journal serves as an instrument for the exchange of high quality data, improving results, advancing science, and as a forum for debate and commentary. Neuromodulation covers an ever expanding field including, pain, headache, movement disorders, spasticity, paralysis, psychiatric disorders, epilepsy, sensory deprivation, gastric dysfunction, obesity, and incontinence.

As the official journal of the International Neuromodulation Society (INS), it represents the international practice of neuromodulation, a growing, diverse multidisciplinary field responsible for the development and application of devices and techniques to benefit patients by normalizing function and reducing suffering.

In-depth reviews, original articles, national and international meeting abstracts, special focus editions, and web-based educational offerings help the reader to expand their knowledge and understanding of the interface between electrical stimulation, chemical neuromodulation, the nervous system and the patient. Neurotechnology reports keep the reader informed of the rapidly changing landscape of the business of neuromodulation, while our updates on past and future news of events and activities of the INS and its membership keep the reader abreast of issues related to professional education and development in this dynamic field.